Monoclonal antibodies against jellyfish collagen
Source abstract
Abstract
Collagens are abundant structural proteins found in both mammalian and marine species, and attractive biomaterials used in various fields. Jellyfish collagen-based products have become increasingly popular because of their clinically proven health benefits such as the effects of skin wound healing and immune stimulation. To develop detection tools for jellyfish collagen, we generated four monoclonal antibodies, MCOL1, 2, 3, and 4, by immunizing mice with moon jellyfish collagen. The nucleotide and amino acid sequences of the variable regions of the monoclonal antibodies were determined. The antibody-binding kinetics toward collagens from moon jellyfish were evaluated using a surface plasmon resonance (SPR) biosensor, and the binding specificity was evaluated in comparison with binding to collagens from edible jellyfish, fish scales, and pig and cow skins. MCOL1, 3, and 4 specifically bound to moon jellyfish collagen, whereas MCOL2 bound to both moon and edible jellyfish collagens. Considering the results showing that the SPR responses of MCOL2 binding were greater than those seen with the other antibodies, MCOL2 could recognize the common and repetitive sequences of the two jellyfish collagens. Therefore, this monoclonal antibody will be most applicable for detecting jellyfish collagen.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Marine Invertebrate Physiology and Ecology · Venomous Animal Envenomation and Studies · Connexins and lens biology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Faculty of Home Economics, Kyoto Women’s University, Kyoto, Japan
Kochi Medical School, Kochi University, Nankoku, Japan
Graduate School of Life and Environmental Sciences, Kyoto Prefectural University, Kyoto, Japan
AI Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Japan
Mitsubishi Tanabe Pharma Corporation, Yokohama, Japan
Funding
Ministry of Education, Culture, Sports, Science and Technology
References (31)
Show source-provided references
1. 10.1177/088532822098027810.1177/0885328220980278 ↗
2. 10.1016/j.actbio.2023.01.02510.1016/j.actbio.2023.01.025 ↗
3. 10.3390/md2204015910.3390/md22040159 ↗
4. 10.1111/1750-3841.1727310.1111/1750-3841.17273 ↗
5. 10.3390/md1903014510.3390/md19030145 ↗
6. 10.1080/10408398.2020.175158510.1080/10408398.2020.1751585 ↗
7. 10.1016/j.foodchem.2017.12.08310.1016/j.foodchem.2017.12.083 ↗
8. 10.1016/j.jhazmat.2023.13109010.1016/j.jhazmat.2023.131090 ↗
9. 10.1016/j.foodchem.2015.09.09410.1016/j.foodchem.2015.09.094 ↗
10. 10.1080/09168451.2015.104636710.1080/09168451.2015.1046367 ↗
11. 10.1007/s10750-012-1039-710.1007/s10750-012-1039-7 ↗
12. 10.1016/j.envint.2022.10769910.1016/j.envint.2022.107699 ↗
13. 10.1016/j.biomaterials.2006.10.02510.1016/j.biomaterials.2006.10.025 ↗
14. 10.1002/term.199310.1002/term.1993 ↗
15. 10.1016/j.reth.2021.06.00810.1016/j.reth.2021.06.008 ↗
16. 10.3390/md2104020110.3390/md21040201 ↗
17. 10.1016/j.molimm.2013.11.00310.1016/j.molimm.2013.11.003 ↗
18. 10.3390/md2004026610.3390/md20040266 ↗
19. 10.3390/pharmaceutics1505133110.3390/pharmaceutics15051331 ↗
20. 10.1016/bs.apcsb.2017.07.00310.1016/bs.apcsb.2017.07.003 ↗
21. 10.1016/j.ymeth.2024.03.00710.1016/j.ymeth.2024.03.007 ↗
22. 10.1016/j.abb.2024.11006810.1016/j.abb.2024.110068 ↗
23. 10.3177/jnsv.68.22110.3177/jnsv.68.221 ↗
24. 10.1016/S0022-1759(99)00184-210.1016/S0022-1759(99)00184-2 ↗
25. 10.1093/nar/gkn31610.1093/nar/gkn316 ↗
26. Chemical Computing Group ULC. 1010 Sherbrooke St. West, Suite #910. Molecular Operating Environment (MOE) 2022. 2022.
27. 10.1084/jem.2013096810.1084/jem.20130968 ↗
28. 10.1111/j.1742-4658.2006.05168.x10.1111/j.1742-4658.2006.05168.x ↗
29. 10.1006/jmbi.1997.156410.1006/jmbi.1997.1564 ↗
30. 10.1093/bioinformatics/btm40410.1093/bioinformatics/btm404 ↗
31. 10.1093/nar/gki01010.1093/nar/gki010 ↗